Chemoinformaics analysis of Oxacyclotetradecan-2-one
| Molecular Weight | 212.333 | nRot | 0 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 30 |
| Exact Molecular Weight | 212.178 | nRing | 1 |
| Solubility: LogS | -3.944 | nHRing | 1 |
| Solubility: LogP | -0.446 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 39.317 |
| nHD | 0 | BPOL | 26.681 |
| QED | 0.159 |
| Synth | 4.675 |
| Natural Product Likeliness | 2.173 |
| NR-PPAR-gamma | 0.935 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.967 |
| HIA | 0.89 |
| CACO-2 | -6.293 |
| MDCK | 0.0000444 |
| BBB | 0.161 |
| PPB | 0.832165 |
| VDSS | 0.736 |
| FU | 0.200737 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.026 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.445 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.155 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.008 |
| CL | 1.29 |
| T12 | 0.445 |
| hERG | 0.014 |
| Ames | 0.76 |
| ROA | 0.066 |
| SkinSen | 0.019 |
| Carcinogencity | 0.136 |
| EI | 0.006 |
| Respiratory | 0.014 |
| NR-Aromatase | 0.953 |
| Antiviral | Yes |
| Prediction | 0.792242 |